BDT Capital Partners acquires a majority interest in MJH Life Sciences
We are advising BDT Capital Partners on the transaction
Davis Polk is advising BDT Capital Partners, LLC on its acquisition through its affiliated funds of MJH Life Sciences. The Hennessy Family, who founded MJH Life Sciences, will continue to hold a significant minority ownership position. The transaction is expected to close later this year and is subject to customary regulatory and other conditions. Financial terms of the transaction were not disclosed.
BDT Capital Partners provides family- and founder-led businesses with long-term, differentiated capital. The firm has raised nearly $19 billion across its investment funds and its global investor base has invested an additional $10 billion of debt and equity in the funds’ portfolio companies. MJH Life Science is the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes.
The Davis Polk corporate team includes partner Evan Rosen and associates Dmitriy Molchanov, Doug Howell and Yoel Levi. Partner J.W. Perry and associate Jack Orford are providing finance advice. Partner David H. Schnabel is providing tax advice. Partner Veronica M. Wissel and counsel Kevin A. Brown are providing executive compensation advice. Partner Frank J. Azzopardi is providing intellectual property advice. All members of the Davis Polk team are based in the New York office.